Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day

Gabi Shemesh, Elad Moisseiev*, Moshe Lazar, Shimon Kurtz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science